Updates on the Implementation of the Newly Amended PRC Patent Law

Published date07 June 2021
Subject MatterFDA,Patents,Life Sciences,China,Prescription Drugs,Patent Applications,Chinese Medicine,Pharmaceutical Patents,Intellectual Property Protection,Patent Registration,CNIPA
AuthorYingli Wang, PH.D.,Jian Wen,Aolei Li
Law FirmPerkins Coie

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT